Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00530218 · BASELINE

Baseline characteristics

Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant · Source last updated 2017-12-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      61
    units
    Participants
groups
  1. description
    Blood Culture at Day 21 or later -or- PCR Test at Day 21 or later
    id
    BG000
    title
    All Study Participants
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          61
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          19
          upper Limit
          58
          value
          41
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          25
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          36
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          61
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
population Description
All patients start out in the "No CMV Reactivation" period, at least until day 21 when the first blood culture or PCR tests are performed. After one positive blood culture or two consecutive positive PCR tests, patients move to the "CMV Reactivation Detected" period. Tests are performed twice weekly from day 21 post-transplant to day 100.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      61
    units
    Participants
groups
  1. description
    Blood Culture at Day 21 or later -or- PCR Test at Day 21 or later
    id
    BG000
    title
    All Study Participants
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          61
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          19
          upper Limit
          58
          value
          41
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          25
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          36
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          61
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
population Description
All patients start out in the "No CMV Reactivation" period, at least until day 21 when the first blood culture or PCR tests are performed. After one positive blood culture or two consecutive positive PCR tests, patients move to the "CMV Reactivation Detected" period. Tests are performed twice weekly from day 21 post-transplant to day 100.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice